Current Beat

Jul | 10 | 2024
Press Release
Remix Therapeutics™ Attains Near-Term Milestone from Roche Collaboration
The collaboration leverages Remix’s REMasterTM platform to discover novel drugs for a diverse range of target classes  Remix is eligible to receive up to $1 billion in milestone payments and royalties Watertown, Mass. (July 10th, 2024) – Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers […]
Filter by: All
Media Contact
Lisette Steele
Verge Scientific Communications

What We've Been Up To